These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5787150)

  • 1. Effects of ethinylestradiol-induced cholestasis on bile flow and biliary excretion of estradiol and estradiol glucuronide by the rat.
    Kreek MJ; Peterson RE; Sleisenger MH; Jeffries GH
    Proc Soc Exp Biol Med; 1969 Jun; 131(2):646-50. PubMed ID: 5787150
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of 17 alpha-ethinylestradiol on the biliary metabolites of 17 beta-[6,7-3H2]estradiol in the rat.
    Watanabe H
    Biochim Biophys Acta; 1971 Mar; 231(2):399-405. PubMed ID: 5554907
    [No Abstract]   [Full Text] [Related]  

  • 3. [The enterohepatic circulation of estradiol and ethinylestradiol in the rat].
    Löffler S; Bolt HM
    Arzneimittelforschung; 1980; 30(5):810-3. PubMed ID: 7190425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of an enterohepatic system in the metabolism of 17beta-estradiol-17-glucosiduronate in the human female.
    Musey PI; Green RN; Hobkirk R
    J Clin Endocrinol Metab; 1972 Sep; 35(3):448-57. PubMed ID: 5051368
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of cholestasis induced by estradiol-17 beta-D-glucuronide in the rat.
    Meyers M; Slikker W; Pascoe G; Vore M
    J Pharmacol Exp Ther; 1980 Jul; 214(1):87-93. PubMed ID: 7391975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of biliary bicarbonate secretion in ethinyl estradiol-induced cholestasis is not associated with impaired activity of the Cl-/HCO-3 exchanger in the rat.
    Alvaro D; Gigliozzi A; Piat C; Carli L; Fraioli F; Romeo R; Francia C; Attili AF; Capocaccia L
    J Hepatol; 1997 Jan; 26(1):146-57. PubMed ID: 9148006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biliary excretion of probenecid and its glucuronide.
    Guarino AM; Schanker LS
    J Pharmacol Exp Ther; 1968 Dec; 164(2):387-95. PubMed ID: 5699099
    [No Abstract]   [Full Text] [Related]  

  • 8. Water-soluble products of the estrogens. Bile metabolites of 2-hydroxyestradiol-17beta in man.
    Elce JS; Bird CE; Chandra J
    J Clin Endocrinol Metab; 1973 May; 36(5):1027-30. PubMed ID: 4698236
    [No Abstract]   [Full Text] [Related]  

  • 9. Biliary permeability during ethinyl estradiol-induced cholestasis studied by segmented retrograde intrabiliary injections in rats.
    Iqbal S; Mills CO; Elias E
    J Hepatol; 1985; 1(3):211-9. PubMed ID: 4067253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ethinyl estradiol and phenobarbital on bile acid synthesis and biliary bile acid and cholesterol excretion.
    Davis RA; Kern F
    Gastroenterology; 1976 Jun; 70(6):1130-5. PubMed ID: 1269874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fate of mestranol (17 -ethynylestradiol-3-methyl ether) in the isolated perfused rat liver.
    Bolt HM; Remmer H
    Horm Metab Res; 1973 Mar; 5(2):101-5. PubMed ID: 4350573
    [No Abstract]   [Full Text] [Related]  

  • 12. [Enterohepatic blood circulation and sex hormone metabolism in human].
    Bolt W; Ritzl F; Bolt HM
    Munch Med Wochenschr; 1966 Apr; 108(16):875-8. PubMed ID: 6014228
    [No Abstract]   [Full Text] [Related]  

  • 13. Estradiol-17 beta-glucuronide-induced cholestasis. Effects of ursodeoxycholate-3-O-glucuronide and 3,7-disulfate.
    Sano N; Takikawa H; Yamanaka M
    J Hepatol; 1993 Feb; 17(2):241-6. PubMed ID: 8445238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectively reduced biliary excretion of cholyldiglycylhistamine but not of cholyltetraglycylhistamine in ethinyl estradiol-treated rats. A possible indicator of increased bile canalicular permeability.
    Mills CO; Iqbal S; Elias E
    J Hepatol; 1985; 1(3):199-210. PubMed ID: 4067252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No increase of biliary permeability in ethinylestradiol-treated rats.
    Jaeschke H; Krell H; Pfaff E
    Gastroenterology; 1983 Oct; 85(4):808-14. PubMed ID: 6884706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanism of the ethynylestradiol impairment of bile flow and bile salt excretion in the rat.
    Gumucio JJ; Valdivieso VD
    Gastroenterology; 1971 Sep; 61(3):339-44. PubMed ID: 5099233
    [No Abstract]   [Full Text] [Related]  

  • 17. Fat storage, de-etherification and elimination of quinestrol in the rat as influenced by route of administration.
    Meli A; Steinetz BG; Giannina T; Cargill DI; Manning JP
    Proc Soc Exp Biol Med; 1968 Apr; 127(4):1042-8. PubMed ID: 5655640
    [No Abstract]   [Full Text] [Related]  

  • 18. Spontaneous reversal of ethinyl estradiol-induced cholestasis in the rat.
    Tritapepe R; Di Padova C; Rovagnati P
    Experientia; 1980 May; 36(5):580-1. PubMed ID: 7379963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the interaction between estrogen metabolites and taurocholate for uptake into isolated hepatocytes. Lack of correlation between cholestasis and inhibition of taurocholate uptake.
    Brock WJ; Durham S; Vore M
    J Steroid Biochem; 1984 May; 20(5):1181-5. PubMed ID: 6727367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of diosgenin, a plant-derived steroid, on bile secretion and hepatocellular cholestasis induced by estrogens in the rat.
    Accatino L; Pizarro M; Solís N; Koenig CS
    Hepatology; 1998 Jul; 28(1):129-40. PubMed ID: 9657105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.